share_log

Autolus Therapeutics Cut to Neutral From Buy by Redburn

Dow Jones Newswires ·  Mar 10, 2021 20:30

DJ Autolus Therapeutics Cut to Neutral From Buy by Redburn

Ratings actions from Benzinga: https://www.benzinga.com/stock/AUTL/ratings

(END) Dow Jones Newswires

March 10, 2021 07:30 ET (12:30 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment